Scripps VIVO scripps research logo

  • Index
  • Log in
  • Home
  • People
  • Organizations
  • Research
  • Events
Search form
As of April 1st VIVO Scientific Profiles will no longer updated for faculty, and the link to VIVO will be removed from the library website. Faculty profile pages will continue to be updated via Interfolio. VIVO will continue being used behind the scenes to update graduate student profiles. Please contact helplib@scripps.edu if you have questions.
How to download citations from VIVO | Alternative profile options
placeholder image
Publications in VIVO
 
    Export Publications Table
co-author
Co-author Network
map of science
Map of Science

Inoue, M.

share the uri
  • Publications
scroll to property group menus

Publications

recent publications

  • academic article

    • Ma, L., Uchida, H., Nagai, J., Inoue, M., Chun, J., Aoki, J., Ueda, H. Lysophosphatidic acid-3 receptor-mediated feed-forward production of lysophosphatidic acid: An initiator of nerve injury-induced neuropathic pain Molecular Pain  2009 5:64  DOI:10.1186/1744-8069-5-64  PMID:19912636  PMCID:PMC2780384
    • Inoue, M., Xie, W., Matsushita, Y., Chun, J., Aoki, J., Ueda, H. Lysophosphatidylcholine induces neuropathic pain through an action of autotaxin to generate lysophosphatidic acid Neuroscience  2008 152:296-298  DOI:10.1016/j.neuroscience.2007.12.041  PMID:18280050
    • Inoue, M., Ma, L., Aoki, J., Chun, J., Ueda, H. Autotaxin, a synthetic enzyme of lysophosphatidic acid (LPA), mediates the induction of nerve-injured neuropathic pain Molecular Pain  2008 4:6  DOI:10.1186/1744-8069-4-6  PMID:18261210  PMCID:PMC2277392
    • Inoue, M., Yamaguchi, A., Kawakami, M., Chun, J., Ueda, H. Loss of spinal substance P pain transmission under the condition of LPA1 receptor-mediated neuropathic pain Molecular Pain  2006 2:25  DOI:10.1186/1744-8069-2-25  PMID:16914035  PMCID:PMC1562366
    • Inoue, M., Rashid, M. H., Fujita, R., Contos, J. J. A., Chun, J., Ueda, H. Initiation of neuropathic pain requires lysophosphatidic acid receptor signaling Nature Medicine  2004 10:712-718  DOI:10.1038/nm1060  PMID:15195086
    • Tan-No, K., Ohshima, K., Taira, A., Inoue, M., Niijima, F., Nakagawasai, O., Tadano, T., Nylander, T., Silberring, J., Terenius, L., Kisara, K. Antinociceptive effect produced by intracerebroventricularly administered dynorphin a is potentiated by p-hydroxymercuribenzoate or phosphoramidon in the mouse formalin test Brain Research  2001 891:274-280  DOI:10.1016/s0006-8993(00)03225-x  PMID:11164832
    • Tan-No, K., Taira, A., Inoue, M., Ohshima, K., Sakurada, T., Sakurada, C., Nylander, I., Demuth, H. U., Silberring, J., Terenius, L., Tadano, T., Kisara, K. Intrathecal administration of p-hydroxymercuribenzoate or phosphoramidon/bestatin-combined induces antinociceptive effects through different opioid mechanisms Neuropeptides  1998 32:411-415  DOI:10.1016/s0143-4179(98)90064-6  PMID:9845000
    • TanNo, K., Taira, A., Sakurada, T., Inoue, M., Sakurada, S., Nylander, I., Silberring, J., Tadano, T., Sato, T., Sakurada, C., Terenius, L., Kisara, K. Inhibition of dynorphin-converting enzymes prolongs the antinociceptive effect of intrathecally administered dynorphin in the mouse formalin test European Journal of Pharmacology  1996 314:61-67  DOI:10.1016/s0014-2999(96)00518-3  PMID:8957219

©2022 The Scripps Research Institute | Terms of Use | Powered by VIVO

  • About
  • Contact Us
  • Support